Chronic pain is more than a lingering sensation; it is a reflection of profound neuroplastic changes within the brain. In Jaffal [1]'s recent review article, "Neuroplasticity in chronic pain: insights into diagnosis and treatment," he compellingly outlines how persistent pain induces structural and functional remodeling of the brain. These changes include reductions in gray matter volume, altered connectivity, and the reorganization of critical networks such as the central executive network, default mode network, and salience network. Such changes impair sensory and emotional processing and contribute to the reinforcement and persistence of pain over time.

This emerging recognition of chronic pain as a disease of the brain has profound implications for both global and local contexts. Worldwide, chronic pain affects more than 1.5 billion people, placing a significant burden on individuals, families, and healthcare systems [2]. Yet, in many low- and middle-income countries, including the Philippines, chronic pain remains underdiagnosed and inadequately treated. Cultural beliefs, stigma, and limited access to specialized care often compel individuals to normalize or ignore their pain until it becomes deeply entrenched and debilitating [3].

Dr. Jaffal’s insights compel us to rethink (our approach to) pain management. Neuroimaging studies now show that chronic pain physically alters key brain regions such as the anterior cingulate cortex, insula, prefrontal cortex, thalamus, and hippocampus. These findings represent a paradigm shift: pain is not merely a symptom to be managed but a neurological condition to be diagnosed and treated at its roots [4]. Importantly, structural and functional brain changes offer a valuable opportunity to develop diagnostic markers and targeted therapies grounded in the principles of neuroplasticity.

Incorporating this knowledge into Philippine healthcare, however, presents both challenges and opportunities. Advanced neuroimaging technologies remain limited, (particularly) outside major urban centers [5]. Nonetheless, practical strategies such as upskilling healthcare workers on the neurobiology of pain, promoting early intervention, and integrating psychosocial therapies can yield meaningful improvements. Community health programs that emphasize cognitive behavioral therapy, mindfulness, and graded physical activity—all aimed at reshaping maladaptive neural circuits—could offer low-cost yet effective solutions.

Globally, as well as locally, the next critical step is research. As Dr. Jaffal rightly notes, neuroplasticity offers a promising framework for understanding and treating chronic pain. Nevertheless, further studies are needed to validate imaging biomarkers and therapeutic approaches across diverse populations. Most current data is derived from Western cohorts. To ensure the global applicability of emerging diagnostic and treatment strategies, it is imperative to include culturally and genetically diverse populations—such as those in Southeast Asia—in future research efforts.

Chronic pain should no longer be regarded as an inevitable consequence of injury or disease, especially in resource-limited settings. It must be recognized as a dynamic, modifiable brain disorder. By applying cutting-edge neuroscientific insights to both clinical practice and public health initiatives, we can create a future in which chronic pain is diagnosed earlier, treated more effectively, and perhaps even prevented.

From the clinics of Seoul to the villages of Luzon and beyond, the challenge, and the opportunity, is clear. Chronic pain demands a new model of care, one informed by neuroplasticity, grounded in empathy, and committed to equitable access for all.